Cancer-Targeting Compound 1 ( —— )

产品货号. M33205 CAS No. 1007581-62-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Cancer-Targeting Compound 1
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Cancer-Targeting Compound 1 可用于与激素相关的癌症研究，摘自专利 WO 2008021331 A2。
产品描述

Cancer-Targeting Compound 1 is used in the research of hormone-?related cancer, extracted from patent WO 2008021331 A2.
体外实验

Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.
体内实验

——
同义词

——
通路

Others
靶点

Other Targets
受体

Others
研究领域

——
适应症

——

1. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.

计算器

产品手册

关联产品

PI-55

PI-55 是特异性 cytokinin receptor 抑制剂。PI-55 在结构上与 6-benzylaminopurine (BAP) 相关，并被证明能竞争性地抑制 BAP 与拟南芥特异性受体 CRE1/AHK4 和 AHK3 的结合。PI-55 抑制细胞分裂素诱导吸器形成和寄生虫侵袭性增加。
Didymin

Didymin 具有抗氧化特性。 Didymin 通过抑制神经母细胞瘤中的 N-Myc 和上调 RKIP 来诱导细胞凋亡，可用于神经母细胞瘤治疗。
(Iso)-WAY-260022

(Iso)-WAY-260022 ((Iso)-NRI-022) is a stereoisomer of WAY-260022, a norepinephrine reuptake inhibitor and selective inhibitor of 5-hydroxytryptamine and dopamine transport proteins.